港股異動 | 深圳國際大漲近9% 年度盈利大增4.5倍至16.22億港元
格隆匯3月20日丨深圳國際(0152.HK)大漲近9%,報12.76元,總市值276億元。深圳國際今日午間發佈公告,截至2019年12月31日止年度,公司總收入達168.2億港元,同比增長45%;公司集團核心業務收入及經營盈利再創歷史新高並分別較去年同期上升45%至港幣149.86億元及42%至港幣55.89億元。物流業務於本年度的收入及股東應占盈利較去年同期顯着增長約1.8倍至港幣78.45億元及約4.5倍至港幣16.22億元;每股盈利2.34港元,末期股息每股0.53港元及特別股息每股0.64港元。中金最新研報指數,市場波動加大及降息預期強化之下,可以關注諸如深圳國際等高股息股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.